Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 35

Results For "API"

3149 News Found

PHARMEXCIL holds high-level talks with government to boost India’s pharma exports
News | January 06, 2026

PHARMEXCIL holds high-level talks with government to boost India’s pharma exports

India’s pharmaceutical sector stands at a pivotal inflection point


RedHill Biopharma advances RHB-102 as once-daily oral therapy to combat GLP-1 side effects
Clinical Trials | January 06, 2026

RedHill Biopharma advances RHB-102 as once-daily oral therapy to combat GLP-1 side effects

The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation


Nia Therapeutics unveils first implantable brain interface for memory disorders
News | January 06, 2026

Nia Therapeutics unveils first implantable brain interface for memory disorders

The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices


Insilico Medicine teams up with Servier to fast-track AI-driven cancer drugs
R&D | January 06, 2026

Insilico Medicine teams up with Servier to fast-track AI-driven cancer drugs

Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments


BioInvent’s experimental combo shows promise in hard-to-treat ovarian cancer
Clinical Trials | January 06, 2026

BioInvent’s experimental combo shows promise in hard-to-treat ovarian cancer

Pembrolizumab has shown meaningful benefit only when combined with chemotherapy


Jaguar Health wins $240,000 FDA grant to advance dog cancer diarrhea treatment
News | January 05, 2026

Jaguar Health wins $240,000 FDA grant to advance dog cancer diarrhea treatment

The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1


FibroBiologics moves experimental psoriasis therapy into FDA review
News | January 04, 2026

FibroBiologics moves experimental psoriasis therapy into FDA review

The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline


Elanco scores USDA nod for new canine allergy drug Befrena
News | January 04, 2026

Elanco scores USDA nod for new canine allergy drug Befrena

Elanco expects Befrena to launch in the US in the first half of 2026


Aarti Pharmalabs appoints Dr. Rakeshwar Bandichhor as Chief Scientific Officer
People | January 04, 2026

Aarti Pharmalabs appoints Dr. Rakeshwar Bandichhor as Chief Scientific Officer

Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories


BioVarta 2025 puts the spotlight on translating biotech innovation into impact
News | January 04, 2026

BioVarta 2025 puts the spotlight on translating biotech innovation into impact

Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale